Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-02-05

Clinical Trial Update: Identification of Patients With a High Probability of Meeting Eligibility Criteria for an Alzheimer's Disease Clinical Trial (APHELEIA)

View source ↗

Summary

This completed study describes a method to identify patients who are highly likely to meet eligibility criteria for an Alzheimer's disease clinical trial. It fo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Global Alzheimer's Platform Foundation | Conditions: Alzheimer Disease, Mild Cognitive Impairment | Status: COMPLETED